|
PESHAWAR, Pakistan, Nov. 18, 2025 /PRNewswire/ -- The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) hosted a high-profile Radiology Continuing Medical Education (CME) session on "Innovations in Cardiovascular Imaging," drawing senior cardiologists, radiologists, and imaging specialists from across Pakistan for an exchange on cutting-edge developments in cardiac imaging and diagnostic technologies.
As part of the CME program, Bill Faruki, Founder & CEO of MindHYVE.ai™, was invited to join the event for a live demonstration of ChironAI™ — MindHYVE's flagship Agentic Healthcare Intelligence Platform.
During the session, Mr. Faruki showcased how ChironAI™ applies advanced reasoning and ethics-embedded AI to assist clinicians in radiology and cardiovascular imaging. Demonstrations included the platform's ability to perform multi-pass image analysis, generate transparent diagnostic reasoning traces, and deliver explainable insights — all while maintaining global medical-ethics standards.
The audience — comprising leading radiologists and cardiovascular experts — responded enthusiastically, describing ChironAI's reasoning capabilities as "a compelling vision for the future of medical imaging" and commending its potential to support diagnostic precision while upholding transparency and trust in clinical AI.
"It was an honor to be part of PIC-MTI's Radiology CME and to engage with such an accomplished community of imaging professionals," said Bill Faruki, CEO of MindHYVE.ai. "ChironAI™ was designed to make AI in healthcare not only powerful but explainable — and the response from PIC's expert audience was deeply encouraging."
MindHYVE.ai™ expressed appreciation to the Peshawar Institute of Cardiology for the invitation and recognized the institute's leadership in promoting innovation and continuous learning within Pakistan's cardiovascular imaging community.
About Peshawar Institute of Cardiology – MTI
The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) is a government tertiary cardiac and teaching hospital in Khyber Pakhtunkhwa, Pakistan, dedicated to advancing cardiovascular care, education, and research for the region and beyond.
About MindHYVE.ai™
MindHYVE.ai™ is redefining the boundaries of intelligence by engineering autonomous systems and deploying domain-specific AGI agents across real-world sectors. Powered by the Ava-Fusion™ large reasoning model and architected for agent coordination, swarm intelligence, and adaptive autonomy, MindHYVE's technology stack is revolutionizing law, medicine, finance, education, and governance.
With operations in North America, Asia, and Africa, MindHYVE.ai™ is on a mission to democratize access to transformative intelligence and architect the infrastructure for post-scarcity economies. Backed by HYVE Labs, the company continues to shape the future of agentic systems on a global scale.
Website: www.mindhyve.ai | Email: hello@mindhyve.io | Contact: +1 (949) 200-8668
Media Contact:
Marc Ortiz
Email: marc.ortiz@mindhyve.io
PESHAWAR, Pakistan, Nov. 18, 2025 /PRNewswire/ -- The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) hosted a high-profile Radiology Continuing Medical Education (CME) session on "Innovations in Cardiovascular Imaging," drawing senior cardiologists, radiologists, and imaging specialists from across Pakistan for an exchange on cutting-edge developments in cardiac imaging and diagnostic technologies.
As part of the CME program, Bill Faruki, Founder & CEO of MindHYVE.ai™, was invited to join the event for a live demonstration of ChironAI™ — MindHYVE's flagship Agentic Healthcare Intelligence Platform.
During the session, Mr. Faruki showcased how ChironAI™ applies advanced reasoning and ethics-embedded AI to assist clinicians in radiology and cardiovascular imaging. Demonstrations included the platform's ability to perform multi-pass image analysis, generate transparent diagnostic reasoning traces, and deliver explainable insights — all while maintaining global medical-ethics standards.
The audience — comprising leading radiologists and cardiovascular experts — responded enthusiastically, describing ChironAI's reasoning capabilities as "a compelling vision for the future of medical imaging" and commending its potential to support diagnostic precision while upholding transparency and trust in clinical AI.
"It was an honor to be part of PIC-MTI's Radiology CME and to engage with such an accomplished community of imaging professionals," said Bill Faruki, CEO of MindHYVE.ai. "ChironAI™ was designed to make AI in healthcare not only powerful but explainable — and the response from PIC's expert audience was deeply encouraging."
MindHYVE.ai™ expressed appreciation to the Peshawar Institute of Cardiology for the invitation and recognized the institute's leadership in promoting innovation and continuous learning within Pakistan's cardiovascular imaging community.
About Peshawar Institute of Cardiology – MTI
The Peshawar Institute of Cardiology – Medical Teaching Institute (PIC-MTI) is a government tertiary cardiac and teaching hospital in Khyber Pakhtunkhwa, Pakistan, dedicated to advancing cardiovascular care, education, and research for the region and beyond.
About MindHYVE.ai™
MindHYVE.ai™ is redefining the boundaries of intelligence by engineering autonomous systems and deploying domain-specific AGI agents across real-world sectors. Powered by the Ava-Fusion™ large reasoning model and architected for agent coordination, swarm intelligence, and adaptive autonomy, MindHYVE's technology stack is revolutionizing law, medicine, finance, education, and governance.
With operations in North America, Asia, and Africa, MindHYVE.ai™ is on a mission to democratize access to transformative intelligence and architect the infrastructure for post-scarcity economies. Backed by HYVE Labs, the company continues to shape the future of agentic systems on a global scale.
Website: www.mindhyve.ai | Email: hello@mindhyve.io | Contact: +1 (949) 200-8668
Media Contact:
Marc Ortiz
Email: marc.ortiz@mindhyve.io
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
MindHYVE's ChironAI™ Showcased at Peshawar Institute of Cardiology's CME on Cardiovascular Imaging Innovation"
HONG KONG, Dec. 8, 2025 /PRNewswire/ -- On 8 December 2025, NOVOSENSE Microelectronics (Stock Codes: 02676.HK; 688052.SH) was officially listed on the Main Board of the Hong Kong Stock Exchange, successfully establishing a dual-capital platform across the A-share and H-share markets. This milestone marks a new chapter in the company's global expansion strategy.
NOVOSENSE positions Hong Kong as its overseas base, serving as a strategic hub to enhance global customer engagement, strengthen supply chain collaboration, and accelerate ecosystem development. This will further reinforce the company's participation and influence in the international analog semiconductor industry.
As one of the few Chinese companies with deep technology and product deployment across three core domains—sensors, signal chain, and power management—NOVOSENSE has built strong competitive advantages in automotive electronics, industrial & energy applications, and smart devices. With a scalable technology platform and comprehensive product portfolio, the company is progressing from "China's trusted analog benchmark" toward becoming a "global partner of choice."
Wang Shengyang, Founder, Chairman, and CEO of NOVOSENSE, remarked that the Hong Kong listing is not only a major milestone in the company's business development, but also the beginning of a new global narrative. Anchored by this listing, NOVOSENSE will continue to invest in foundational technologies, expand its product portfolio, strengthen overseas sales and marketing capabilities, and enhance global operational excellence—delivering long-term value to customers and partners worldwide.
About NOVOSENSE Microelectronics
NOVOSENSE Microelectronics (NOVOSENSE, SSE Stock Code 688052 HKEX: 02676.HK) is a highly robust & reliable analog and mixed signal chip company. Since its establishment in 2013, the company has been focusing on sensor, signal chain, and power management, providing comprehensive semiconductor products and solutions, which are widely used in automotive, industrial, information communication and consumer electronics markets.
With the mission of "Sense & Drive the Future, Build a Green, Smart and Connected World with Semiconductors", the company is committed to providing chip-level solutions to link the digital world and the real world.
For more information, please visit: https://www.novosns.com/en
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
NOVOSENSE Successfully Listed on HKEX, Strengthening Its Foundation to Serve Global Customers
